Larvol Delta - ContraFect-Data-Presentations-at-the-32nd-Annual-ECCMID-Meeting-Highlight-the-Potential-of-Engineered-Lysin-CF370-to-Improve-Clinical-Outcomes-and-Suppress-Antimicrobial-Resistance-Compared-to-Antibiotics-Alone

CF-370 - ContraFect

https://www.globenewswire.com/news-release/2022/04/27/2430176/0/en/ContraFect-Data-Presentations-at-the-32nd-Annual-ECCMID-Meeting-Highlight-the-Potential-of-Engineered-Lysin-CF-370-to-Improve-Clinical-Outcomes-and-Suppress-Antimicrobial-Resistanc.html

Apr 27, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next